Status:
COMPLETED
The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Based on data regarding the effect of colchicine on the modulation of immune system and decreasing cytokine release and inflammation the question arises whether colchicine, administered in a relativel...
Detailed Description
80 Patients with positive nasopharyngeal swab PCR for COVID-19 which were not hypoxic but showed computed tomography involvement compatible with COVID-19 admitted in ward (not in Intensive care unit) ...
Eligibility Criteria
Inclusion
- Patients \>18 years old with nasopharyngeal swab confirmed COVID-19 PCR, CT involvement compatible with COVID, Fever and Dyspnea without hypoxemia.
Exclusion
- Patient who is not willing to enter in study
- Known hypersensitivity to colchicine
- Hepatic failure
- Renal failure with eGFR\<20 ml/min
Key Trial Info
Start Date :
March 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04360980
Start Date
March 20 2020
End Date
January 30 2021
Last Update
January 28 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
SBMU
Tehran, Iran, 1666664321
2
Nooshin Dalili
Tehran, Iran